The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Fertility Medicines Market Research Report 2024
Synopsis
Fertility medicines
The global Fertility Medicines market was valued at US$ 4636.8 million in 2023 and is anticipated to reach US$ 6842.7 million by 2030, witnessing a CAGR of 5.8% during the forecast period 2024-2030.
Infertility continues to pose a global health challenge due to demographic changes and ongoing lifestyle issues, including obesity, anxiety, stress and other factors that lead to delayed childbearing. For example, according to alcoholic beverage consumption statistics released in February 2023, approximately 63% of adults aged 18 and older in the United States drank alcohol between 2021 and 2022. Additionally, 12.5% of adults in the UK reported teetotaling, while the drinking rate among adults in the country was 71.2% (drinking at least once a week), according to data released by UK Alcohol Consumption Statistics in February 2023. Therefore, heavy drinking can affect fertility in both men and women. In turn, it is expected to boost demand for infertility drugs over the forecast period.
The low fertility rate prevalent among the population is also a key factor driving the market growth. For example, in July 2022, about 15% of U.S. couples and at least 180 million people worldwide were suffering from infertility, according to an article published by the U.S. National Library of Medicine.
This report aims to provide a comprehensive presentation of the global market for Fertility Medicines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fertility Medicines.
Report Scope
The Fertility Medicines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Fertility Medicines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fertility Medicines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan Plc
Ferring BV
Merck KGaA
Novartis AG
Sanofi
Bayer AG
Pfizer Inc.
Abbott
Teva Pharmaceutical Industries
Livzon
Segment by Type
Parenteral
Oral
Others
Segment by Application
Clinic
Hospitals
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Fertility Medicines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Fertility Medicines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Fertility medicines
The global Fertility Medicines market was valued at US$ 4636.8 million in 2023 and is anticipated to reach US$ 6842.7 million by 2030, witnessing a CAGR of 5.8% during the forecast period 2024-2030.
Infertility continues to pose a global health challenge due to demographic changes and ongoing lifestyle issues, including obesity, anxiety, stress and other factors that lead to delayed childbearing. For example, according to alcoholic beverage consumption statistics released in February 2023, approximately 63% of adults aged 18 and older in the United States drank alcohol between 2021 and 2022. Additionally, 12.5% of adults in the UK reported teetotaling, while the drinking rate among adults in the country was 71.2% (drinking at least once a week), according to data released by UK Alcohol Consumption Statistics in February 2023. Therefore, heavy drinking can affect fertility in both men and women. In turn, it is expected to boost demand for infertility drugs over the forecast period.
The low fertility rate prevalent among the population is also a key factor driving the market growth. For example, in July 2022, about 15% of U.S. couples and at least 180 million people worldwide were suffering from infertility, according to an article published by the U.S. National Library of Medicine.
This report aims to provide a comprehensive presentation of the global market for Fertility Medicines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fertility Medicines.
Report Scope
The Fertility Medicines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Fertility Medicines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fertility Medicines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan Plc
Ferring BV
Merck KGaA
Novartis AG
Sanofi
Bayer AG
Pfizer Inc.
Abbott
Teva Pharmaceutical Industries
Livzon
Segment by Type
Parenteral
Oral
Others
Segment by Application
Clinic
Hospitals
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Fertility Medicines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Fertility Medicines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Fertility Medicines Market Overview
1.1 Product Overview and Scope of Fertility Medicines
1.2 Fertility Medicines Segment by Type
1.2.1 Global Fertility Medicines Market Value Comparison by Type (2024-2030)
1.2.2 Parenteral
1.2.3 Oral
1.2.4 Others
1.3 Fertility Medicines Segment by Application
1.3.1 Global Fertility Medicines Market Value by Application: (2024-2030)
1.3.2 Clinic
1.3.3 Hospitals
1.4 Global Fertility Medicines Market Size Estimates and Forecasts
1.4.1 Global Fertility Medicines Revenue 2019-2030
1.4.2 Global Fertility Medicines Sales 2019-2030
1.4.3 Global Fertility Medicines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Fertility Medicines Market Competition by Manufacturers
2.1 Global Fertility Medicines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Fertility Medicines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Fertility Medicines Average Price by Manufacturers (2019-2024)
2.4 Global Fertility Medicines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Fertility Medicines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Fertility Medicines, Product Type & Application
2.7 Fertility Medicines Market Competitive Situation and Trends
2.7.1 Fertility Medicines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Fertility Medicines Players Market Share by Revenue
2.7.3 Global Fertility Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Fertility Medicines Retrospective Market Scenario by Region
3.1 Global Fertility Medicines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Fertility Medicines Global Fertility Medicines Sales by Region: 2019-2030
3.2.1 Global Fertility Medicines Sales by Region: 2019-2024
3.2.2 Global Fertility Medicines Sales by Region: 2025-2030
3.3 Global Fertility Medicines Global Fertility Medicines Revenue by Region: 2019-2030
3.3.1 Global Fertility Medicines Revenue by Region: 2019-2024
3.3.2 Global Fertility Medicines Revenue by Region: 2025-2030
3.4 North America Fertility Medicines Market Facts & Figures by Country
3.4.1 North America Fertility Medicines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Fertility Medicines Sales by Country (2019-2030)
3.4.3 North America Fertility Medicines Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Fertility Medicines Market Facts & Figures by Country
3.5.1 Europe Fertility Medicines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Fertility Medicines Sales by Country (2019-2030)
3.5.3 Europe Fertility Medicines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Fertility Medicines Market Facts & Figures by Country
3.6.1 Asia Pacific Fertility Medicines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Fertility Medicines Sales by Country (2019-2030)
3.6.3 Asia Pacific Fertility Medicines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Fertility Medicines Market Facts & Figures by Country
3.7.1 Latin America Fertility Medicines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Fertility Medicines Sales by Country (2019-2030)
3.7.3 Latin America Fertility Medicines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Fertility Medicines Market Facts & Figures by Country
3.8.1 Middle East and Africa Fertility Medicines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Fertility Medicines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Fertility Medicines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Fertility Medicines Sales by Type (2019-2030)
4.1.1 Global Fertility Medicines Sales by Type (2019-2024)
4.1.2 Global Fertility Medicines Sales by Type (2025-2030)
4.1.3 Global Fertility Medicines Sales Market Share by Type (2019-2030)
4.2 Global Fertility Medicines Revenue by Type (2019-2030)
4.2.1 Global Fertility Medicines Revenue by Type (2019-2024)
4.2.2 Global Fertility Medicines Revenue by Type (2025-2030)
4.2.3 Global Fertility Medicines Revenue Market Share by Type (2019-2030)
4.3 Global Fertility Medicines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Fertility Medicines Sales by Application (2019-2030)
5.1.1 Global Fertility Medicines Sales by Application (2019-2024)
5.1.2 Global Fertility Medicines Sales by Application (2025-2030)
5.1.3 Global Fertility Medicines Sales Market Share by Application (2019-2030)
5.2 Global Fertility Medicines Revenue by Application (2019-2030)
5.2.1 Global Fertility Medicines Revenue by Application (2019-2024)
5.2.2 Global Fertility Medicines Revenue by Application (2025-2030)
5.2.3 Global Fertility Medicines Revenue Market Share by Application (2019-2030)
5.3 Global Fertility Medicines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Allergan Plc
6.1.1 Allergan Plc Corporation Information
6.1.2 Allergan Plc Description and Business Overview
6.1.3 Allergan Plc Fertility Medicines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Allergan Plc Fertility Medicines Product Portfolio
6.1.5 Allergan Plc Recent Developments/Updates
6.2 Ferring BV
6.2.1 Ferring BV Corporation Information
6.2.2 Ferring BV Description and Business Overview
6.2.3 Ferring BV Fertility Medicines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Ferring BV Fertility Medicines Product Portfolio
6.2.5 Ferring BV Recent Developments/Updates
6.3 Merck KGaA
6.3.1 Merck KGaA Corporation Information
6.3.2 Merck KGaA Description and Business Overview
6.3.3 Merck KGaA Fertility Medicines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck KGaA Fertility Medicines Product Portfolio
6.3.5 Merck KGaA Recent Developments/Updates
6.4 Novartis AG
6.4.1 Novartis AG Corporation Information
6.4.2 Novartis AG Description and Business Overview
6.4.3 Novartis AG Fertility Medicines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis AG Fertility Medicines Product Portfolio
6.4.5 Novartis AG Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Corporation Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi Fertility Medicines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sanofi Fertility Medicines Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
6.6 Bayer AG
6.6.1 Bayer AG Corporation Information
6.6.2 Bayer AG Description and Business Overview
6.6.3 Bayer AG Fertility Medicines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bayer AG Fertility Medicines Product Portfolio
6.6.5 Bayer AG Recent Developments/Updates
6.7 Pfizer Inc.
6.6.1 Pfizer Inc. Corporation Information
6.6.2 Pfizer Inc. Description and Business Overview
6.6.3 Pfizer Inc. Fertility Medicines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Inc. Fertility Medicines Product Portfolio
6.7.5 Pfizer Inc. Recent Developments/Updates
6.8 Abbott
6.8.1 Abbott Corporation Information
6.8.2 Abbott Description and Business Overview
6.8.3 Abbott Fertility Medicines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Abbott Fertility Medicines Product Portfolio
6.8.5 Abbott Recent Developments/Updates
6.9 Teva Pharmaceutical Industries
6.9.1 Teva Pharmaceutical Industries Corporation Information
6.9.2 Teva Pharmaceutical Industries Description and Business Overview
6.9.3 Teva Pharmaceutical Industries Fertility Medicines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Teva Pharmaceutical Industries Fertility Medicines Product Portfolio
6.9.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.10 Livzon
6.10.1 Livzon Corporation Information
6.10.2 Livzon Description and Business Overview
6.10.3 Livzon Fertility Medicines Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Livzon Fertility Medicines Product Portfolio
6.10.5 Livzon Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Fertility Medicines Industry Chain Analysis
7.2 Fertility Medicines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Fertility Medicines Production Mode & Process
7.4 Fertility Medicines Sales and Marketing
7.4.1 Fertility Medicines Sales Channels
7.4.2 Fertility Medicines Distributors
7.5 Fertility Medicines Customers
8 Fertility Medicines Market Dynamics
8.1 Fertility Medicines Industry Trends
8.2 Fertility Medicines Market Drivers
8.3 Fertility Medicines Market Challenges
8.4 Fertility Medicines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
